Triple antiplatelet therapy during percutaneous coronary intervention is associated withimproved outcomes including one-year survival

Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group

Ralph B. D’Agostino · Statistics in Medicine · 1998 · 5.4K citations

Public Health, Biostatistics, Causal Inference +16

Early and Sustained Dual Oral Antiplatelet Therapy Following Percutaneous Coronary Intervention

Steven R. Steinhubl, Peter B. Berger, J. Tift Mann et al. · JAMA · 2002 · 3.1K citations

Medicine, Cardiology, Pharmacotherapy +14

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

Shamir R. Mehta, Salim Yusuf, Ron J.G. Peters et al. · The Lancet · 2001 · 2.8K citations

Medicine, Cardiology, Pharmacotherapy +16

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

Shamir R. Mehta, Salim Yusuf, Ron J.G. Peters · ACC Current Journal Review · 2002 · 2.6K citations

Medicine, Cardiology, Pharmacotherapy +16

A Randomized Comparison of Antiplatelet and Anticoagulant Therapy after the Placement of Coronary-Artery Stents

Albert Schömig, Franz–Josef Neumann, Adnan Kastrati et al. · New England Journal of Medicine · 1996 · 2K citations

Medicine, Cardiology, Pharmacotherapy +17